You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Ph I Topic 314 Fibrous Scaffold-induced Spheroids Mimicking TME
SBC: TRANSGENEX NANOBIOTECH, INC. Topic: NCINot Available
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
PDX Pharmaceuticals
SBC: PDX PHARMACEUTICALS, INC. Topic: NCIOver one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted therapies, including Herceptin and lapatinib, account for 55% of the breast cancer therapy market in 2011 (or 5 billion annually). Response to HER2-targeted therapies typically average about one year ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
FLUORESCENT NANODIAMONDS FOR IN VITRO AND IN VIVO BIOLOGICAL IMAGING- SBIR TOPIC
SBC: COLUMBUS NANOWORKS, INC. Topic: NHLBIThe purpose of Phase I isto develop a biocompatible fluorescent label that never photobleaches or blinks, and that is brighter than commonly used dyes. PUBLIC HEALTH RELEVANCE
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
IGF::OT::IGF: Smokescreen: Genetic Screening Tool for Tobacco Dependence and Treatm
SBC: BIOREALM, LLC Topic: NIDAIn this SBIR Phase II contract, the contractor shall develop and test Smokescreen for research, specifically, manufacturing the custom genotyping array and software based on specifications gathered in Phase I, and testing and optimizing Smokescreen in diverse smoking-related research applications. PUBLIC HEALTH RELEVANCE
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Stability and functionality of the Immunoject single-dose, auto-reconstitution de
SBC: AKTIV-DRY Topic: N/ADESCRIPTION (provided by applicant): Assuring the success of mass campaigns against bioterrorist or naturally occurring pathogens requires that vaccines, therapeutics, and other products are stored and ready for immediate use at the time the threat to public health is perceived. Storage is a major contributor to the cost of administration under these circumstances and a requirement to keep the act ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Electrical Impedance Myography for the Assessment of Neck and Low Back Pain
SBC: MYOLEX, INC. Topic: NIAMSDESCRIPTION (provided by applicant): Low back and neck pain are two of the most common medical problems. In a recent study, 26.4% of individuals had an episode of severe low back pain and 13.8% severe neck pain in the preceding 3 months. Moreover, low backor neck pain is the major complaint in 3% of all office visits to primary care physicians (PCPS), and 5% of all healthcare visits overall. Altho ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
High-Throughput Ex Vivo Tumor Cell Motility Assay
SBC: NANOFIBER SOLUTIONS LLC Topic: N/ADESCRIPTION (provided by applicant): Gliomas are the most aggressive and least successfully treated brain tumors because of their distinctive ability to infiltrate surrounding brain tissue. Even if the bulk of the tumor is removed, migratory cells left behind are not detected by the immune system and resist current cytotoxic therapies. Tumor recurrence then typically involves a rapid and deadly ou ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
